0.06
-1.54%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Pharmx Technologies
Its shares trade on ASX under the ticker PHX.AX. It has been listed since 28 July 1971. In the fiscal year to 30 June 2026, it reported revenue of A$7.6m and a net loss of A$1.8m. At that date it held total assets of A$27.3m and shareholders' equity of A$23.3m.
Pharmx Technologies Ltd is a AU-based company operating in Software industry. The company is headquartered in Sydney, New South Wales. PharmX Technologies Limited, formerly Corum Group Limited, is an Australian company that operates a network connecting retail pharmacies and suppliers in Australia and New Zealand. The firm offers PharmX, an electronic gateway that links pharmacies, pharmaceutical wholesalers and direct suppliers within the pharmacy market, and PharmXchange, a digital sales and marketing platform integrated with PharmX. The firm is also focused on creating a more productive environment for pharmacy and suppliers, with additional ordering functions, such as stock checks, credits, and auto account set up direct from their point of sale (POS) system.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Information Technology
- Industry
- Software
- Listed since
- 28 Jul 1971
- Website
- corumgroup.com.au ↗
Leadership
Pay as last reported
- Mr. Nick EnglandNon-Executive Chairman of the Board, since 2019A$291,132
- Mr. Thomas CulverChief Executive Officer
- Mr. Andrew Jonathan George NewberyInterim Chief Financial Officer, Executive Director, since 2020A$96,800
- Mr. James NevileChief Operating OfficerA$285,365
- Mr. Christopher FernandesCompany Secretary
- Mr. Dennis BastasNon-Executive DirectorA$81,233
- Ms. Jayne ShawNon-Executive DirectorA$94,875
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- PharmX connects retail pharmacies and suppliers across Australia and New Zealand effectively.
- PharmXchange integrates digital sales and marketing with PharmX for seamless operations.
- PharmX offers stock checks, credits, and auto account setup from POS systems efficiently.
Weaknesses
- Pharmx Technologies Ltd has been listed since 28 July 1971 without recent expansion details.
- The company operates solely within Australia and New Zealand without international presence.
- Pharmx Technologies Ltd's business model relies on pharmacy market connections only.
Opportunities
- Expanding PharmX to include more international pharmacy networks could increase market reach.
- Integrating additional ordering functions like inventory management could enhance PharmX features.
- Growing demand for digital platforms in the pharmacy sector presents new opportunities.
Threats
- Competition from other pharmacy network solutions in Australia and New Zealand may arise.
- Regulatory changes in the pharmaceutical industry could impact PharmX operations.
- Economic downturns might reduce spending on pharmacy digital solutions.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.